|  Help  |  About  |  Contact Us

Publication : IFN-γ-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease.

First Author  Saito A Year  2021
Journal  J Invest Dermatol Volume  141
Issue  6 Pages  1473-1481.e4
PubMed ID  33242500 Mgi Jnum  J:320997
Mgi Id  MGI:6729794 Doi  10.1016/j.jid.2020.09.033
Citation  Saito A, et al. (2021) IFN-gamma-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease. J Invest Dermatol 141(6):1473-1481.e4
abstractText  Patients with graft-versus-host disease (GVHD) develop characteristic mucocutaneous phenomena consisting of erosive erythema with histopathological findings including interface dermatitis and keratinocyte (KC) death, resulting in widespread sclerodermatous changes. We found that KCs exhibit marked production of TGFbeta1 in skin lesions of chronic GVHD but not in those of acute GVHD. To further investigate the roles of KCs, the main targets of donor T cells, in sclerodermatous changes followed by interface dermatitis, we established a murine model of chronic GVHD-like sclerodermatous changes followed by acute GVHD-like mucocutaneous injury in genetically modified mice transferred with KC-specific CD8 T cells. Although transfer of granzyme B-deficient CD8 T cells did not result in either mucocutaneous injury or sclerodermatous changes in recipients, IFN-gamma-deficient CD8 T-cell recipients developed severe acute mucocutaneous injury but milder sclerodermatous changes than wild-type CD8 T-cell recipients. Moreover, IFN-gamma-deficient CD8 T-cell recipients had a lower expression of TGFbeta1 in the epidermis than the control. Murine primary KCs undergoing FasL-induced apoptosis and incubated with IFN-gamma produced TGFbeta1, the production of which was inhibited by a pan-caspase inhibitor. Our results indicate that IFN-gamma promotes TGFbeta1 production by apoptotic KCs, which mediates the development of widespread sclerodermatous changes in KC-targeting GVHD.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

Trail: Publication

0 Expression